AlphaStocks
5.3
Consider Buy

Bruker Corp (BRKR)

As of Sep 20, 2026, Bruker Corp (BRKR) scores 5.3/10 on AlphaStocks' five-model composite, #96 of 168 Health Care stocks. At $61, BRKR trades 31% above its model fair value of $47.

Health Care / Health Care Equipment

S&P MidCap 400

$61.39

Below average on several measures. Research carefully.

Consider Buy

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#96out of 168 in Health Care

Is BRUKER CORP a Good Investment in 2026?

BRUKER CORP (BRKR) scores 5.3 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Lynch model rates BRUKER CORP as Attractive. However, the Graham model rates it Caution. BRUKER CORP currently trades 31% above its estimated fair value of $47. BRUKER CORP ranks #96 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE-0.4Market Cap9B

Estimated Fair Value

$46.9331% above

Trading above estimated fair value — the market may be pricing in future growth.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

4/9

Buffett

Caution

Business quality & competitive moat

Graham

Caution

Price vs intrinsic value

Lynch

Attractive

Growth rate vs price (PEG)

Greenblatt

Attractive

Earnings yield 5.1% · ROC 33%

Frequently Asked Questions

Is BRUKER CORP (BRKR) a good investment?
As of Sep 20, 2026, Bruker Corp (BRKR) scores 5.3/10 on AlphaStocks' five-model composite, #96 of 168 Health Care stocks. At $61, BRKR trades 31% above its model fair value of $47. That score is below average, suggesting caution.
What is BRUKER CORP's Piotroski F-Score?
BRUKER CORP's Piotroski F-Score status is Neutral. The raw score is 4/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is BRKR overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $47, BRKR appears overvalued. The stock currently trades 31% above its estimated fair value. Trading above estimated fair value — the market may be pricing in future growth.
How does BRKR compare to other Health Care stocks?
BRUKER CORP ranks #96 out of 168 stocks in the Health Care sector, placing it in the top 57% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about BRKR?
AlphaStocks evaluates BRKR using five proven investment models. Piotroski: Neutral; Buffett: Caution; Graham: Caution; Lynch: Attractive; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 5.3/10.

Similar Stocks

INSPUFPTBDX

Compare BRKR with

BRKR vs INSPBRKR vs UFPTBDX vs BRKR

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer